Recent Share Performance Puts Anterix in Focus

Anterix (ATEX) has moved onto more investors’ watchlists after a sharp run in the stock, with returns of about 40% over the past month and a very large gain over the past 3 months.

The recent surge in Anterix’s share price, including a 10.7% 1 day share price return and a 145.7% 90 day share price return, sits on top of a 249.2% 1 year total shareholder return. This suggests strong momentum has been building over both shorter and longer periods.

If Anterix’s move has you thinking about where else strong price action could show up next, it may be worth scanning 35 power grid technology and infrastructure stocks as another way to uncover potential opportunities linked to grid and infrastructure themes.

With Anterix now trading above its consensus price target yet still flagged by some metrics as below intrinsic value, the key question is whether recent momentum leaves meaningful upside on the table or the market is already pricing in future growth.

Most Popular Narrative: 104% Overvalued

Compared with Anterix’s last close at $89.67, the most followed narrative anchors on a fair value of $44.00, creating a wide valuation gap for investors to weigh.

Although utilities are showing interest in private broadband networks as they modernize grids, Anterix still has roughly 85% of its spectrum yet to be monetized. Any delay in converting that interest into contracts could slow the realization of expected spectrum value and defer cash inflows and earnings.

Want to see how that unmonetized spectrum is modeled? The narrative leans heavily on revenue growth, margin shifts and a future earnings multiple that looks unusually stretched.

Result: Fair Value of $44.00 (OVERVALUED)

However, if utilities accelerate grid connectivity projects or if Anterix clears and licenses remaining spectrum faster than expected, that could challenge the current overvaluation narrative.

Another View On Anterix’s Valuation

The bearish narrative pegs Anterix’s fair value at $44.00. Our DCF model, however, suggests a different picture, with Anterix trading at $89.67 compared with an estimated future cash flow value of $120.39, which screens as undervalued. Which set of assumptions do you consider more realistic?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Anterix for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 44 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mix of optimism and caution around Anterix feels finely balanced, consider acting promptly. Review the underlying data for yourself and weigh the 3 key rewards and 3 important warning signs.

Looking For More Investment Ideas Beyond Anterix?

If Anterix has sharpened your interest in focused research, do not stop here; widen your watchlist with other clear, data backed ideas before the crowd moves on.

• Spot potential value opportunities early by reviewing companies in the 44 high quality undervalued stocks that combine discounted prices with quality fundamentals.
• Prioritize resilience by scanning the 71 resilient stocks with low risk scores to see stocks that pair steadier risk profiles with more robust financial characteristics.
• Hunt for lesser known opportunities by checking the screener containing 19 high quality undiscovered gems where strong fundamentals have not yet attracted as much attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.